what is a microdose of retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Injection: Package Insert /

This approach initially appears counterintuitive

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management as Zepbound

While details are still being finalized, this represents an important step toward ensuring access, though it does not provide immediate relief for commercial plans

This creates an individualized optimization challenge: finding the lowest dose that produces satisfactory results while minimizing adverse effects